Patients diagnosed with Prurigo Nodularis, A skin disease that causes hard, itchy lumps (nodules) to form on the skin, will be enrolled to evaluate new treatments for this skin condition. Clinical trial participants will be monitored closely by medical professionals for the duration of the study. The goal of this Prurigo Nodularis clinical trial is to develop better understanding of Prurigo Nodularis and develop safe and effective therapies.
Up to 136 weeks depending on study
Subject compensation and travel assistance may be available. Study medication, study related exams, and lab tests will be provided at no cost
For general questions regarding our clinical trials, please contact our team at email@example.com or fill out the contact form below.
A clinical trial is a research study conducted with human volunteers to test the effectiveness and safety of new drugs, devices, or interventions. Our Clearlyderm clinical trials focus on skin conditions such as psoriasis, acne, rosacea, or atopic dermatitis (eczema).
To enroll in one of our clinical trials, contact our office. You will need to review and complete informed consent documents and complete screening procedures prior to participation.
Like any medical treatment, potential risks exist. However, participants are informed of these risks prior to starting the clinical trials and receive monitoring and follow-up care throughout the trial duration if selected to participate.
Prurigo Nodularis (PN) is a chronic skin disorder that leads to hard, itchy bumps called nodules. Nodules can range in size from a couple of millimeters to the size of a quarter. They may be reddish-brown, flesh colored, or brownish-black.